A new protein-based coronavirus treatment could reduce severe symptoms by nearly 80% - what it means for patients
A new protein-based coronavirus treatment could dramatically reduce the number of patients who suffer severe symptoms and require intensive care, according to preliminary trial results.
The treatment, developed by Southampton-based biotech Syniargen, has been hailed as a “major breakthrough” in the fight to find an effective drug treatment against the virus.
Advertisement
Hide AdAdvertisement
Hide Ad